May 14th, 2014
Informed Interpretation of the 20-Year Results of the DIGAMI Trial
Valentin Fuster, MD
Darren McGuire gives us his perspective on the DIGAMI trial results.
NEJM — Recent Cardiology Articles- Utah’s Prescription-Renewal Pilot Program — Autonomous AI Managing Patient Care April 23, 2026Utah recently rolled out a pilot program involving an AI system that autonomously renews certain prescriptions for people with chronic conditions. This program raises important clinical and legal issues.
- Double Take: HFpEF Explained — Prevalence, New Advances, and How to Diagnose April 23, 2026This Double Take video reviews heart failure with preserved ejection fraction, its risk factors and causes, and the challenge in establishing the diagnosis.
- Blood-Pressure Control after Intracerebral Hemorrhage — An Unbroken Glass Ceiling April 23, 2026Effective blood-pressure control is the cornerstone of management after intracerebral hemorrhage; it is both the primary determinant of risk and the most vital intervention for reducing the threat of a second vascular event.1 Yet, despite the availability of effective treatments, blood pressure remains poorly controlled in survivors of...
- Three Low-Dose Antihypertensive Agents in a Single Pill after Intracerebral Hemorrhage April 23, 2026Among survivors of intracerebral hemorrhage, a single pill with three low-dose antihypertensive agents added to standard care was associated with a lower incidence of stroke and major cardiovascular events than placebo.
- Glucocorticoids in Kawasaki Disease — Refining Indications and the Science April 16, 2026Kawasaki disease is the most common cause of acquired heart disease in children in the developed world.1 Although Kawasaki disease manifests with acute, transient systemic signs, its long-term morbidity derives from necrotizing vasculitis that predominantly affects the coronary arteries.2,3 The primary goal of therapy during the...
- Utah’s Prescription-Renewal Pilot Program — Autonomous AI Managing Patient Care April 23, 2026